Featured Article

New PAH Treatment System Submitted for FDA Approval

2019-10-07T17:43:07+00:00October 3rd, 2019|

Trevyent®, a new treatment system that utilizes subcutaneous delivery of treprostinil for pulmonary arterial hypertension (PAH) patients, was submitted to the U.S. Food & Drug Administration (FDA) for approval. The FDA received a New Drug Application (NDA) by United Therapeutics Corporation in September for Trevyent, a disposable pump and skin patch system or PatchPump®

Volunteer Spotlight: Treating the Condition and Beyond

2019-10-03T18:27:53+00:00October 3rd, 2019|

Kristine Ritenour, a pulmonary hypertension (PH) nurse coordinator at the Medical University of South Carolina, serves as the Pulmonary Hypertension Association (PHA) support group leader of the Lowcountry Charleston Support Group in Charleston, S.C. Kristine started leading a support group because she believes it’s important to give patients a place to connect and learn more

Online Registration Closes for PHA on the Road – Kansas City on Oct. 8

2019-10-03T17:19:36+00:00October 3rd, 2019|

We are just one week away from the Pulmonary Hypertension Association’s (PHA’s) free PHA on the Road education forum at the Sheraton Overland Park Hotel in Kansas City, Kan., on Oct. 12. PHA on the Road is a free educational event for those living with pulmonary hypertension (PH) and their loved ones to learn more about the

Stay Up to Date on PHA 2020 Announcements

2019-10-03T17:21:45+00:00October 3rd, 2019|

Are you looking for more information about the Pulmonary Hypertension Association (PHA) 2020 International Pulmonary Hypertension (PH) Conference and Scientific Sessions? Sign up for updated notifications and information to help you prepare for next year’s event, June 12-14, in Anaheim, Calif. As always, PHA 2020 includes a PH Conference for the patient community and

Health Care Professionals Share Why They Participate in and Lead PHA Support Groups

2019-09-27T19:37:43+00:00September 26th, 2019|

Many of the 350 volunteers leading the Pulmonary Hypertension Association’s (PHA’s) more than 200 support groups are patients and caregivers. But there is also another group of these leaders who by pulmonary hypertension (PH) in a different way: they diagnose and treat it. Sarah Miranda, M.S.N, R.N., pulmonary vascular coordinator, Korman Respiratory Institute-Thomas Jefferson

Volunteer Spotlight: PHA Support Group Leader Loves Making an Impact in the PH Community

2019-09-26T18:21:56+00:00September 26th, 2019|

Heather Arena, Pulmonary Hypertension Association (PHA) Support Group of Michiana leader in St. Joseph, Mich., shares her passion and joy for being a support group leader and how it helps her connect with the pulmonary hypertension (PH) community. “I wanted to become a support group leader when I became involved with our patients who

Oxygen Survey May Lead to Better Technology and Advocacy

2019-09-26T20:37:06+00:00September 26th, 2019|

A team of Johns Hopkins University (Hopkins) engineering graduate students discovered the difficulties people with lung diseases experience accessing and obtaining portable oxygen equipment while shadowing Hopkins pulmonologists in 2018. They were inspired to take action. They learned from individual patients about the impact current portable oxygen equipment has on living a normal lifestyle